Low-dose radiation given to two mouse models of pulmonary hypertension depleted disease-causing cells, preventing and reversing the development of the condition,…
Articles by Iqra Mumal, MSc
Actelion Pharmaceuticals has received a complete response letter from the U.S. Food and Drug Administration (FDA) specifying that the company needs…
Arterial stiffness, a marker of atherosclerosis, is significantly greater in patients with chronic thromboembolic pulmonary hypertension (CTEPH) compared to…
Exhaled breath temperature could serve as a potential prognostic biomarker for patients with pulmonary hypertension (PH), a new study shows.
Mylan recently introduced a formulation of 20 mg tadalafil tablets, the first generic version of Eli Lilly‘s Adcirca,…
The emotional well-being of people with pulmonary hypertension (PH), particularly in relation to levels of anxiety and depression, may be…
The U.S. Food and Drug Administration has approved Medtronic’s Implantable System for Remodulin, or ISR, to deliver Remodulin to patients…
Patients with pulmonary hypertension have little daily exercise, often at levels so low their their odds of survival are…
British researchers have identified rare mutations of four genes that could lead to pulmonary arterial hypertension. The team said scientists…
Levosimendan improved right ventricular function in a rat model of pulmonary hypertension, supporting its potential as an effective therapy for…
Primary pulmonary hypertension (PH), age extremes (less than 6 months or older than 16 years), invasive interventions, and co-diagnoses with…
Vivus announced that it is in discussions with the U.S. Food and Drug Administration (FDA) to possibly test tacrolimus —…